Unlocking Better Outcomes for Adults with Congenital Heart Disease
Thomas Young, MD
JAMA Network Open - October 16, 2024
PMID: 39412804
A recent publication in JAMA Network Open helps to shed light on the quality of life and health outcomes among adults with congenital heart disease (CHD) through critical findings from the Congenital Heart Initiative (CHI) registry.
Read more
Apixaban vs Aspirin in Patients with Cancer and Cryptogenic Stroke
Richard Zweifler, MD
Joseph Tarsia, MD
JAMA Neurology - August 12, 2024
PMID: 39133474
Ochsner Health physicians Dr. Richard Zweifler and Dr. Joseph Tarsia are co-authors on a paper published in JAMA Neurology on a post hoc analysis carried out in the ARCADIA randomized clinical trial.
Read more
Frailty Scores Predict Outcomes in Stroke Patients After Urgent Carotid Procedures
Hernan Bazan, MD
Journal of Vascular Surgery - August 5, 2024
PMID: 39111588
An innovative study by Dr. Hernan Bazan at Ochsner Health and colleagues reveals how frailty assessments can accurately predict outcomes in urgent carotid artery interventions for stroke patients.
Read more
Enhancing Nasal Endoscopy with AI
Edward D. McCoul, MD
International Forum of Allergy & Rhinology - June 10, 2024
PMID: 38853655
Ochsner Health researchers authored an article exploring the application of convolutional neural networks (CNNs) to improve the accuracy and efficiency of nasal endoscopy.
Read more
Comparative Study on Dual vs Single Cardioversion for Atrial Fibrillation in Obese Patients
Daniel Morin, MD
JAMA Cardiology - May 22, 2024
PMID: 38776097
A team of Ochsner Health cardiologists recently published an article in JAMA Cardiology comparing two treatment strategies for patients with atrial fibrillation and obesity.
Read more
Ochsner Health Highlights Innovative Non-Opioid Pain Therapy Candidate Publication
Hernan Bazan, MD
Scientific Reports - May 15, 2024
PMID: 38750093
A potentially groundbreaking non-opioid pain treatment has been developed by a team led by Dr. Hernan Bazan, the John Ochsner Endowed Professor of Cardiovascular Innovation at Ochsner Health.
Read more
Improving Life Quality in Chronic Limb-Threatening Ischemia Through Revascularization
Christopher White, MD
Circulation - April 16, 2024
PMID: 38597097
A recent article highlights an assessment of the impact of revascularization strategies on the health-related quality of life of patients suffering from chronic limb-threatening ischemia.
Read more
Exploring the Impact of Pancreatic Enzyme Therapy in Pediatric Pancreatitis: A Leap Toward Personalized Medicine
Matthew Giefer, MDAmerican Journal of Gastroenterology – March 22, 2024
PMID: 38517077
A new research study explains the role of pancreatic enzyme therapy (PERT) in reducing the frequency of acute pancreatitis (AP) in children suffering from acute recurrent pancreatitis or chronic pancreatitis.
Neoadjuvant Chemotherapy Proves Effective for Locally Advanced Penile Squamous Cell Carcinoma
Kyle Rose, MDJournal of the National Cancer Institute – February 16, 2024
PMID: 38366627
Dr. Kyle Rose, urologic oncologist at Ochsner MD Anderson Cancer Center, examined the effects of neoadjuvant chemotherapy on patients suffering from locally advanced penile squamous cell carcinoma.
